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TI role of eosinophils in inflammation and their
mode of activation is not well understood. Eosi-
nophil accumulation and subsequent expression
of cytokines at the site of inflammation may play
a role in exacerbation of inflammatory respon-
ses. In the present study, we have examined the
role of TNF-a in eosinophil activation and chemo-
kine production using a human leukaemic eosi-
nophil cell line, EOL-1. Initial studies
demonstrated that TNF-a induced the upregula-
tion of IL-8 and MCP-1 mRNA and protein. Kinetic
studies indicated production of chemokines, IL-8
and MCP-1, as early as 4h post-activation, with
peak levels of chemokine produced at 8h, and
decreasing by 24h post-TNF- activation. When
IL-10, a suppressive cytokine, was incubated with
TNF- and EOL-1 cells, no effect was observed on
IL-8 and MCP-1 production. However, dex-
amethasone, a glucocorticoid, demonstrated
potent inhibitory effects on the EOL-l-derived
chemokines. These studies indicate that eosino-
phils may be a significant source of chemokines
capable of participating in, and maintaining, leu-
kocyte recruitment during inflammatory respon-
ses, such as asthma.
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Introduction
Eosinophils are granule-containing cells that
differentiate from stem cell precursors in the
bone marrow, circulate in the blood, and then
enter into peripheral tissues. 1’2 Normally present
at low concentrations, increased levels of circu-
lating and/or tissue eosinophils have been asso-
ciated with diseases such as asthma and parasitic
infections.2’3 The presence of eosinophils during
chronic inflammatory diseases has been asso-
ciated with tissue pathology. In addition, eosino-
phils represent a potential source of cytokines
that may influence chronic inflammatory reac-
tions and other biological responses. The estab-
lishment of a human eosinophilic leukaemia cell
line, EOL-1, has proved to be a useful in vitro
model for studying the properties of eosinophils
and the pathways of their inflammatory respon-
ses and released products.
Cytokines regulate immunologic and physiolo-
gic events by transmitting information to target
cells through receptor-ligand interactions.
4 For
example, it has been shown previously that inter-
leukin-1 (IL-1) and tumour necrosis factor-or
(TNF-cz) act as early response cytokines and can
stimulate a variety of both immune and non-
immune cells to produce additional peptide
mediators, some of which have been shown to
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be important leukocyte chemotactic factors.
4-6
These chemotactic cytokines, or chemokines,
which recruit additional cells to the inflammatory
site, can be divided into two polypeptide groups
based on the position of two internal disulfide
bonds formed from four cysteine amino acid
residues. In one supergene family of chemokines
(C-C chemokine family), exemplified by the
protein monocyte chemoattractant protein-1
(MCP-1), two of the four cysteine amino acid
residues are found in juxtaposition to each other.
The members of this family are predominantly
chemotactic for mononuclear cells, monocytes,
and lymphocytes. In the other division of this
polypeptide family (C-X-C chemotactic cytokines)
two of the four cysteines are separated by one
67 different amino acid. This group, typified by
interleukin-8 (IL-8), is predominantly chemotactic
for neutrophils. Both MCP-1 and IL-8 attract leu-
kocytes to sims of inflammation and have been
identified in various diseases such as rheumatoid
arthritis, atherosclerosis, as well as in multiple
pulmonary diseases.’ In addition, eosinophils
have recently demonstrated the ability to produce
chemokines.9’1
In the present study, we determined the activa-
tion pathway of chemokine production of an
eosinophilic leukemia cell line, EOL-1. Utilizing
this eosinophilic leukaemic cell line we demon-
(C) 1996 Rapid Science PublishersIL-8 and MCP-1 from EOL-1 cells
strated that tumour necrosis factor-cz (TNF-cz) thiocyanate, 0.5% Sarkosyl, and 0.1 M 2-
induces the production of chemokines inter- mercaptoethanol was overlaid on eosinophil
leukin-8 and monocyte chemoattractant protein- monolayers. After homogenization, the above
1. Interestingly, the production of these chemo- suspension was added to a solution containing
kines was not regulated by a suppressive cyto- an equal volume of 100 nM Tris, pH 8.0, 10 mM
kine, interleukin-10, but could be regulated EDTA, and 1.0% SDS. Then, the mixture was
nonspecifically by dexamethasone. Overall, these extracted using chloroform-phenol (1.1. v/v)
studies suggest that eosinophils may contribute and chloroform-isoamyl alcohol (24:1 v/v). The
to chronic inflammatory responses via their total RNA was precipitated by using alcohol and
ability to produce chemotactic cytokines, thus the pellet dissolved in diethyl pyrocarbonate
amplifying the leukocyte recruitment. (DEPC)-treated H20. Total RNA was separated by
electrophoresis using denated formaldehyde, 1%
Materials and Methods agarose gels, followed by transblotting to nitro-
cellulose. Blots were baked, prehybridized, and
Cell culture: The eosinophilic cell line EOL-1 was hybridized with a P-5’ end-labelled oligonucleo-
maintained in RPMI 1640 medium supplemented tide probe specific for IL-8 or MCP-1. The 30-
with 2 mM >glutamine, 24 mM Hepes, 100 I.tg/ml mer oligonucleotide probes for IL-8 and MCP
penicillin, 100 I.tg/ml streptocycin (Hazelton were complementary to the nucleotide sequences
Research Products) and 10% heat-inactivated 5’-GTT-GGC-GCA-GTG-TGG-TCC-ACT-CTC-AAT-
foetal calf serum (FCS) (Gibco Laboratories). CAC-3’ and 5’-TTG-GGT-TTG-CTT-GTC-CAG-
The isolation and characterization of EOL-1 have GTG-GTC-CAT-GGA-3’, respectively. Blots were
been previously described. stringently washed after hybridization and
exposed to X-ray film. Specific chemokine mRNA
Assessment of cytokine levels by specific ELISAs: was quantified using imaging analysis video den-
Specific eosinophil-derived cytokines were quan- sitometry with a frame grabber (Image Capture
tiffed using a modification of a double ligand 1000; Scion Corp., Walkersville, MD) and Image
ELISA method as previously described.
2 Briefly, 1.49 software (National Institutes of Health
flat-bottomed 96-well microtitre plates were Public Software, Bethesda, MD).
coated with 50 I.d/well of rabbit antichemokine
(IL-8 and MCP-1) antibodies (1 t.tg/ml in 0.6 Statistical analysis.. Data were analysed by Macin-
mol/1 NaCl, 0.26 ml/1 H3BO4, and 0.08 N NaOH, tosh II computer using a statistical software
pH 9.6, for 16 h at 4C and then washed with package (Statview II; Abacus Concept, Inc., Ber-
BPS (pH 7.5) 0.05% Tween-20 (wash buffer), keley, CA)and expressed as mean _+ S.E.M. Data
Nonspecific binding sites on microtitre plates that appeared statistically significant were com-
were blocked with 2% BSA in PBS and incubated pared by Student’s t-test for comparing the
for 90 min at 37C. Plates were rinsed three means of multiple groups and considered sig-
times with wash buffer and diluted eosinophil- nificant ifp values were <0.05.
derived conditioned media (50 l.tl) was added,
followed by incubation for i h at 37C. Plates Results were washed three times with wash buffer,
50 l.tl/well of biotinylated rabbit anticytokine (IL-8 Cytokine activation of EOL-I cells.. Previously, it
and MCP-1) antibodies were added for 45 min has been shown that eosinophils produce cyto-
at 37C. After washing, 100 l.tl peroxidase con- kines, such as TNF-cz, which can act on a variety
jugated Avidin (Dako Corp, 1:5 000 dilution)was of cell t.es to upregulate further cytokine pro-
added and incubated 30 min at 37C. Plates were Auction. In the present study, we assessed the
again washed three times and then chromogen production of chemokines, IL-8 and MCP-1, from
substrate OPD was added. The plates were incu- the eosinophilic cell line, EOL-1. Various con-
bated at room temperature to the desired extinc- centrations, 0.1, 1.0, and 10 ng/ml, of IL-1, IFN-,,
tion, the reaction terminated with 50 l.d/well of IL-4, IL-10, and TNF-z were incubated with the
3 M H3SO4 solution and samples were read at EOL-1 cells (1 x 10/ml). After 24h, super-
490 nm in an ELISA reader. The sensitivity of natants were collected and analysed for IL-8 and
this ELISA method is consistently greater than MCP-1 by specific ELISAs. Only TNF-cz-activated
50 pg/ml. EOL-1 cells showed significant cytokine produc-
tion. None of the other cytokines examined
Northern blot analysis ofchemokine mRNA. Total induced chemokine production from the EOL-1
RNA from the EOL-1 cell line was isolated, as cells. Figures 1 and 2 show a dose-dependent
previously described.2’ Briefly, a solution con- increase in IL-8 and MCP-1 production occurring
taining 25 mM Tris, pH 8.0, 4.2 M guanidine iso- when EOL-1 cells were activated with TNF-t.
Mediators of Inflammation Vol 5 1996 219L. A Goldstein et al.
Control
[] IL-1
[] IFN
[] IL-4
[] L-IO
[] TNF
Cytokine Concentration (ng/ml)
FIG. 1. 11_-8 production from cytokine activated EOL-1 cells.
Various concentrations (0.1, 1.0, and 10 ng/ml) were used to
stimulate EOL-1 cells. Culture supernatants were collected at
24h and measured by IL-8 specific ELISA. Data represents the
mean -i- S.E.M. of three repeat experiments.
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FIG. 2. MCP-1 production from cytokine activated EOL-1 cells.
Various concentrations (0.1, 1.0, and 10 ng/ml) were used to
stimulate EOL-1 cells. Culture supernatants were collected at
24h and measured by MCP-1 specific EI_ISA. Data represents
the mean -t-_ S.E.M. of three repeat experiments.
Peak IL-8 and MCP-1 production was observed at
a TNF concentration of 10 ng/ml.
Time-dependent production of EOL-I-derived
chemokines in response to TNF.. To determine
the temporal production of IL-8 and MCP-1, EOL-
1 cells were cultured at 1, 4, 8, or 24h at 37C
with 10 ng/ml of TNF-cz and assessed by specific
ELISAs for IL-8 and MCP-1. As depicted in Figs 3
and 4, EOL-1 cells did not release appreciable
levels of IL-8 or MCP-1 within the first hour. By
4h, significant levels of IL-8 and MCP-1 were
detected that continued to rise and peak at 8 h.
By 24 h post-TNF<z activation cytokine levels had
decreased (IL-8) or were maintained (MCP-1).
Figure 5 shows representative Northern blots of
[] Control
[] TNF (10 ng/ml)
4 8 24
Time of Culture (h)
FIG. 3. Kinetic analysis of IL-8 production in TNF--activated EOL-
cells. TNF (20 ng/ml) was used to stimulate EOL-1 cells.
Culture supernatants were collected at 1, 4, 8, and 24h and
measured by IL-8 specific ELISA. Data represents the means ___
S.E.M. of three repeat experiments.
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FIG. 4. Kinetic analysis of MCP-1 production in TNF-activated
EOL-1 cells. TNF- (20 ng/ml) was used to stimulate EOL-1 cells.
Culture supernatants were collected at 1, 4, 8, and 24h and
measured by MCP-1 specific ELISA. Data represents the means
-t- S.E.M. of three repeat experiments.
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FIG. 5. Representative Northern blots showing kinetic analysis of
EOL-l-derived steady state IL-8 and MCP-1 mRNA production.
TNF- (10 ng/ml) was used to stimulate EOL-1 cells. RNA
extractions were performed on EOL-1 cells cultured at 1, 4, and
24 h. Repeat experiments showed similar results.
EOL-l-derived steady state chemokine mRNA
production. Strong expression of IL-8 mRNA
occurs at 1 and 4h post-TNF-a (10 ng/ml) acti-
vation with continued expression at 24h post-
TNF-a. MCP-1 mRNA production is expressed at
4h post-TNF-a (10 ng/ml) with increased
expression at 24h post-TNF activation. Interest-
ingly, MCP-1 mRNA expression increased in con-
trois at 4 and 24 h timepoints.
Suppression of EOL-I-derived chemokines: To
determine the regulation of IL-8 and MCP-1, EOL-
1 cells were cultured with either IL-10 or dexa-
methasone. IL-10 is known to inhibit cytokine
synthesis in other leukocyte populations,
5-9
whereas dexamethasone, a glucocorticoid,
appears to nonspecifically shutdown cellular acti-
vation events. TNF-a (10 ng/ml)-stimulated EOL-
1 cells were incubated with or without IL-10 (10
ng/ml). Supernatants were collected after 8 h and
samples were assessed for cytokine production
by specific ELISAs. TNF-a-stimulated EOL-1 cells
incubated with IL-10 did not show significant dif-
ferences in IL-8 or MCP-1 (Fig. 6) production. In
fact, IL-10 appeared to augment the TNF driven
It-8 production (p < 0.05). Northern blot analy-
sis confirmed these data, demonstrating no
decrease in either IL-8 or MCP-1 mRNA expres-
sion when IL-10 was added to the cultures (data
not shown). In contrast, when EOL-1 cells were
challenged with TNF-a in the presence of various
doses of dexamethasone (10-v to 10-5 M), a sig-
nifican decrease in both IL-8 and MCP-1 produc-
tion was observed (Fig. 7). Altogether, these data
indicate that although EOL-l-derived chemokine
production can be inhibited by dexamethasone,
[] IL-8
[] MCP-1
.5
FIG. 6. Effect of IL-IO on IL-8 and MCP-1 production in TNF-acti-
vated EOL-1 cells. IL-10 (10 ng/ml) was added to the TNF-acti-
vated (10 ng/ml) EOL-1 cells. Culture supernatants were
collected at 8h and assayed for IL-8 and MCP-1 by specific
ELISAs. Data represents the means S.E.M. of three repeat
experiments.
[] IL8 MEAN
[] MCP MEAN
TNF (10 ng/ml)
FIG. 7. Effect of dexamethasone on chemokine production in
TNF--activated EOL-1 cells. Dexamethasone (10-s to 10
-7 M)
was added to TNF--activated (10 ng/ml) EOL-1 cells. Culture
supernatants were collected at 8h and assayed for IL-8 and
MCP-1 by specific ELISAs. Data represents the means ___
S.E.M.
of three repeat experiments.
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it appears that the regulation of these chemo- cystic fibrosis, IPF, emphysema, ARDS, bronchie-
kines by IL-10 is different compared with other stasis, and chronic bronchitis.25 IL-8 levels have
leukocyte populations, also been detected during late-phase reactions of
asthma.26 In addition, IL-8 is known to be a
Diuion chemoattractant for neutrophils,27’28 eosino-
phils,29 and has been implicated as a lymphocyte
Eosinophilic infiltrations are found in chronic chemotactic protein.
1 These findings suggest
inflammatory responses, such as those observed that eosinophil-derived IL-8 may recruit additional
during parasitic and allergic inflammation2’3 and leukocytes into tissue during an inflammatory/
may play a role in exacerbation of inflammatory/ allergic reaction, thus exacerbating the overall
allergic reactions by perpetuation of leukocyte response.
recruitment. A better understanding of the eosi- MCP-1 is a potent monocyte chemoattractant3
nophil activation pathway and the subsequent and recently has been found to act as a T-lym-
cytokine production cascade would provide phocyte chemoattractant.
1 Activated T-lympho-
useful information for application in immuno- cytes, in addition to eosinophils, have been
therapy during chronic inflammation. Our studies documented to accumulate in tissue during
have confirmed the importance of TNF-cz as a chronic inflammation and more specifically
key activator of eosinophil-like EOL-1 cell induc- during late-phase asthmatic reactions.31 MCP-1
tion of IL-8 and MCP-1 mRNA expression and made by eosinophils may augment T-lymphocyte
protein production. Dose response studies mediated responses via its ability to recruit
demonstrated that TNF-cz was capable of sig- various leukocyte populations to the site of
nificant activation of the IL-8 and MCP-1 from inflammation. Furthermore, eosinophils found at
EOL-1 cells. Time course studies showed that sites of active fibrosis have been shown to
cytokine production occurred within 4 h of incu- express MCP-1 mRNA
1 suggesting that they may
bation with TNF and that culture of eosinophils play an important role in chronic fibrosing dis-
with TNF-cz for 8 h induced peak levels of IL-8 eases.
and MCP-1. Interestingly, incubation of IL-10 with Finally, we determined IL-10 had a minimal
TNF-cz and EOL-1 cells did not affect IL-8 and role in regulating EOL-l-derived IL-8 and MCP-1.
MCP-1 production, while EOL-1 cells could be IL-10 is a cytokine produced by CD4 + cells, B
regulated by dexamethasone. These results cells, certain populations of CD8+ cells,
suggest that EOL-1 cells are regulated by IL-10 Epstein-Barr Virus (EBF)-transformed lympho-
differently than other leukocyte populations, blastoid cell lines, monocytes and macro-
Overall, these studies suggest that eosinophils phages.25’32-34 In addition, IL-10 demonstrates
may significantly contribute to the exacerbation varied immunosuppressive bioactivity on cytokine
of chronic inflammation and upregulate the leu- production and, along with IL-4 and IL-5, is pro-
35 kocyte extravasation through the production of duced during allergic responses. IL-10 down-
chemokines, regulates IFN-7 production associated with Thl
Activation of eosinophils and the subsequent responses as well as monocyte and polymorpho-
release of IL-8 and MCP-1 may be an important nuclear (PMN)-derived cytokine production,
contributing factor during a chronic inflammatory including IL-8.6 In this study we have demon-
response. In particular, the infiltration of eosino- strated that IL-10 does not inhibit cytokine pro-
phils into the lung tissue is known to occur duction from TNF-activated EOL-1 cells. Since
during the late phase of asthma.2-23 It has been eosinophil accumulation appears to be enhanced
previously shown that BAL cells from asthmatics, during Th2 responses and IL-10 does not reg-
as compared to normal controls, express ulate this response, eosinophils may play a sig-
24 increased levels of TNF-specific mRNA. This nificant role in maintaining chronic allergic and
increased production of TNF, which occurs in parasitic responses. However, since IL-10 strongly
conjunction with the presence of eosinophils, regulates the production of TNF from leukocyte
may be a contributing factor for activating the populations IL-10 may indirectly affect the cyto-
eosinophils leading to upregulated chemokine ldne production in vivo from eosinophilic cells.
production. Interestingly, recent studies have A final possibility may be that the EOL-1 cells do
identified eosinophils as a source of TNF sug- not have IL-10 receptors and therefore cannot
gesting that they can also contribute to the respond to the cytokine. Unlike IL-10, dexa-
overall activation of inflammatory responses, methasone did inhibit chemokine production,
The chemokines, IL-8 and MCP-1, which were indicating that the regulation within these cells is
found to be produced by the EOL-1 cells, have similar to other leukocyte populations. The dexa-
been associated with a number of inflammatory methasone induced inhibition of the chemokines
diseases. IL-8 production has been observed in correlates well with the successful use of steroids
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in treatment of chronic eosinophilic disease
states, such as asthma.
Our findings suggest that eosinophils may par-
ticipate in inflammatory/allergic reactions through
the generation of chemokines, IL-8 and MCP-1,
further augmenting leukocyte recruitment. In
addition, IL-10, an inhibitor of monocyte and
PMN-derived cytokines, did not regulate EOL-1-
derived cytokine production, suggesting altered
regulation of this leukocyte subset.
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